Diabesity - novel molecular targets for obesity and type 2 diabetes
 
members  
Index  
Next Member  
Previous Member  
Professor Daniel Ricquier Professor Daniel Ricquier
Faculté de Médecine Necker
Enfants Malades
CNRS UPR 9078
156 Rue de Vaugirard 75730
Paris Cedex 15
France
Phone: +33 140615670
E-mail
Professor Daniel Ricquier
Workpackage 10 leader
homepage
 

Research

Our principal objective in this program is to characterise and validate diabesity drug targets, particularly novel targets identified in other workpackages, by studies of key factors in the regulation of white and brown adipose tissues.  The focus of research in the first 18 months will be on analyses of known drug targets that are a focus of research in this project, particularly nuclear receptors (the transcription factor FOXC2, Rev-erb–a, and glucocorticoid receptors), the corticoid metabolism enzyme 11b-hydroxysteroid dehydrogenase type 1 (11b-HSD-1), and uncoupling proteins (UCPs).  Research will extend after this time to include novel transcription factors, receptors and ligands identified by Consortium members.

 

Diabesity: Novel molecular targets for obesity and type 2 diabetes
   
  home | research | publications | members | events | about diabesity | press | links | contact us